The diagnosis and management of anaphylaxis practice parameter: 2010 update.

By P. Lieberman, R. Nicklas, J. Oppenheimer, S. Kemp, D. Lang, D. Bernstein, J. Bernstein, A. Burks, A. Feldweg, J. Fink and 14 more. Journal of Allergy and Clinical Immunology, 2010

698 citations recorded by the source corpus.

Subfields: Immunology and Allergy, Surgery

View Paper: https://www.semanticscholar.org/paper/3ab57ebcf2718769df8bf6c4c7fe0ece83a0b34d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. V. Cardona
2. I. Ansotegui
3. M. Ebisawa
4. Y. El-gamal
5. Montserrat Fernandez Rivas
6. P. Greenberger
7. M. Worm
8. M. Biló

Citations in the corpus

• Allergen immunotherapy: a practice parameter third update. (2007, background): “C Biphasic anaphylactic reactions are characterized by complete clinical resolution of initial symptoms followed by onset of latephase symptoms, usually within 24 hours.(244) Biphasic anaphylactic reactions are reported to occur 1% to 20% of the time.”
• World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis (2011, background): “tic episodes; however, patients with frequent episodes, that is, more than 6 in 1 year or more than 2 in 2 months, are reported to benefit from prophylactic treatment with a systemic glucocorticoid and an H1-antihistamine.(24,87) Prophylactic omalizumab injections are also reported to reduce the num”
• World allergy organization anaphylaxis guidance 2020 (2020, background): “Guidelines from WAO, the American Academy of Allergy Asthma and Immunology (AAAAI)/ American College of Asthma Allergy and Immunology (ACAAI), and European Academy of Allergy and Clinical Immunology (EAACI) all address the recommendation of follow-up with a physician and if possible with an allergy/”